What is Ipratropium?

An example of Ipratropium

Ipratropium is an anticholinergic drug with similar effects to atropine, but since it is poorly absorbed into the blood, it has few side effects (such as tachycardia) at therapeutic doses. It is available as an inhalant or a nasal spray. It is also used for the reduction of secretions in the lungs.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
30 1 Efficacy_major
21 5 Efficacy_major Efficacy_moderate
6 0
5 2 Efficacy_moderate
4 1 Efficacy_moderate
4 1 Efficacy_major

See all 70 patients currently taking Ipratropium

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
1
Moderate
1
Mild
3
None
9

Commonly reported side effects, conditions, and hospitalizations associated with Ipratropium

2
1
1
1
1
1
See all 6 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Ipratropium. See all 36 dosages

  0.02% as needed 18mcg/inh as needed 0.018 mg daily 0.02 g daily 0.036 mg daily 0.04 g daily 0.06 g daily 0.08 g daily 34 mcg daily 80 mcg daily
  7 Number of Patients: 7 2 Number of Patients: 2 9 Number of Patients: 9 5 Number of Patients: 5 5 Number of Patients: 5 2 Number of Patients: 2 4 Number of Patients: 4 3 Number of Patients: 3 4 Number of Patients: 4 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Ipratropium (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 5   Course of treatment ended: 36%
Doctor's advice 4   Doctor's advice: 29%
Side effects too severe 2   Side effects too severe: 14%
Other 2   Other: 14%
Did not seem to work 1   Did not seem to work: 7%

See all 14 patients who’ve stopped taking Ipratropium

Currently Taking Ipratropium

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Ipratropium

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Ipratropium

Always
9 64%
Usually
1 7%
Sometimes
4 29%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Ipratropium

Very
2 14%
Somewhat
3 21%
A little
3 21%
Not at all
6 43%

Cost

Paid out of pocket

Cost of Ipratropium

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
5 100%

Sort by: Helpfulness | Most Recent

3 patient evaluations for Ipratropium

Purpose: Runny nose (rhinorrhea) (Started Sep 25, 2009)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Oct 03, 2009 0.06 g Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate MildMildMildMildMild SometimesSometimesSometimesSometimesSometimes SomewhatSomewhatSomewhatSomewhatSomewhat
Side effects:
Sinus headaches
  • Icon_thumb_off 0 helpful marks
Purpose: Other (Started Mar 30, 1998)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Mar 30, 2009 0.054 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Date
Mar 30, 2009
Advice & Tips
this is combined treatment with albuterol. treatments take 20 minutes. I experience immediate relief of lung congestion.
  • Icon_thumb_off 0 helpful marks
Purpose: Emphysema (Started Sep 01, 2007)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Apr 04, 2008 As needed Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks

11 additional evaluations for Ipratropium are not currently shared publicly.

What is ipratropium?

Ipratropium inhalation is used to prevent bronchospasm, or narrowing airways in the lungs, in people with bronchitis, emphysema, or COPD (chronic obstructive pulmonary disease).

Ipratropium inhalation may also be used for other purposes not listed in this medication guide.


Precautions

Ipratropium inhalation is used to prevent bronchospasm attacks. This medication will not treat bronchospasm while it is happening. You may still have difficulty breathing and may need to use one of your other medicines to treat the attack. To best control your condition, use ipratropium inhalation regularly, and continue using all your other medicines as directed by your doctor.

Before using ipratropium inhalation, tell your doctor if you have:

  • narrow-angle glaucoma; or
  • an enlarged prostate or a bladder obstruction.

If you have any of these conditions, you may need a dose adjustment or special tests to safely use this medication.

FDA pregnancy category B: This medication is not expected to be harmful to an unborn baby. Do not use ipratropium inhalation without telling your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known if ipratropium passes into breast milk or if it could harm a nursing baby. Do not use ipratropium inhalation without telling your doctor if you are breast-feeding a baby.

Ipratropium inhalation should not be used by a child younger than 12 years of age.

Avoid getting this medication in your eyes. If this happens, rinse with water.

Back to top

Instructions

Seek emergency medical attention if you think you have used too much of this medicine. Ipratropium inhalation is not expected to cause overdose symptoms.

Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and wait until your next regularly scheduled dose. Do not use extra medicine to make up the missed dose.

Back to top

Side Effects

Stop using ipratropium inhalation and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a fast, pounding heartbeat.

Other less serious side effects are more likely to occur, such as:

  • headache, dizziness;
  • dry mouth, cough, hoarseness;
  • nausea, upset stomach; or
  • blurred vision.

If you switch from Atrovent to Atrovent HFA, you may notice a slightly different taste or feel after inhaling the medication.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

Before using ipratropium inhalation, tell your doctor if you are using any of the following medicines:

  • atropine (Donnatal, and others),
  • belladonna,
  • clidinium (Quarzan),
  • dicyclomine (Bentyl),
  • glycopyrrolate (Robinul),
  • hyoscyamine (Anaspaz, Cystospaz, Levsin, and others)
  • mepenzolate (Cantil),
  • methantheline (Provocholine),
  • methscopolamine (Pamine), and
  • propantheline (Pro-Banthine), or
  • scopolamine (Transderm-Scop).

This list is not complete and there may be other drugs not listed that can affect ipratropium inhalation. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Other Names

Atrovent HFA, ipratropium, and Atrovent

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: